A phase II trial of xevinapant in combination with post-operative cisplatin and radiotherapy for high risk head and neck cancer Meeting Abstract
| Authors: | Yu, Y.; Ganly, I.; Sherman, E.; Lee, N. Y. |
| Abstract Title: | A phase II trial of xevinapant in combination with post-operative cisplatin and radiotherapy for high risk head and neck cancer |
| Meeting Title: | 2024 Multidisciplinary Head and Neck Cancers Symposium |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 118 |
| Issue: | 5 |
| Meeting Dates: | 2024 Feb 29-Mar 2 |
| Meeting Location: | Phoenix, AZ |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-04-01 |
| Start Page: | e25 |
| Language: | English |
| DOI: | 10.1016/j.ijrobp.2024.01.059 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl plus with full text |
| DOI/URL: | |
| Notes: | Meeting Abstract: 124 -- Accession Number: 175934724 -- Entry Date: In Process -- Revision Date: 20240313 -- Publication Type: Journal Article -- Journal Subset: Biomedical; Peer Reviewed; USA -- NLM UID: 7603616. -- Source: CINAHL Plus with Full Text |
Altmetric
Citation Impact
BMJ Impact Analytics
